Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Iron overload gene linked to colon cancer:

This article was originally published in Clinica

Executive Summary

Genetic mutations that are associated with hereditary haemochromatosis (HFE), or iron overload, increase the risk of colon cancer by 40%, say US researchers. A 1,300-patient study found that the frequency of the mutations in individuals' HFE genes was much greater in patients with colon cancer, compared with cancer-free people. A test panel of markers for the mutations could help identify those patients who would benefit from intensified colorectal cancer screening, say the study authors, whose findings appear in the Journal of the National Cancer Institute (January 15).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel